Design (Testphase)
Risk & Weakness
Weakness Cluster
211
Findings
July 21, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 25 hits from US
Stage 4 + very weak RS (≤ 15) + price below the 200-day SMA — multiple weakness signals bundled together.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Funda Rating ≥ +10) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth Minnow Street company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from -100 to +100 with a school-grade rank from A+ to F. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- SMA / Moving Average (10-, 20-, 50-, 200-Day Line)
- The average price of the last X days, plotted as a line on the chart (Simple Moving Average). The 50-day and 200-day lines are the most closely watched: price above the line = uptrend intact. The 30-week line from the Weinstein method corresponds to the 150-day line.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STEP Stepstone Group Inc | 08/06 | +34 % | 54 5/22 | Stage 4 | C +9 | 4 of 9 | 5.5 | Asset Management | – | — | — | Financial Services | 42.30 $ | -31.4 % | -37.4 % | -19.9 % | −47.4 % | +77.2 % | 15 | 18 | 6.2 % | 5.7 % | 1.30 | — | 16.8 | 2.7 | — | 85.6 | — | 16.5 | -3.5 % | -41.9 % | -26.9 % | -55.9 % | -11.3 % | — | -6.1 % | +69.7 % | 4.1 % | 77.3 % | 3.0 | 103.3 % | 8.6 % | 1.5 (6) |
| PSN Parsons Corp | 08/05 | +1 % | 19 3/25 | Stage 4 | D -13 | 3 of 9 | 5.0 | Information Technology Servi | – | — | — | Technology | 55.50 $ | -20.3 % | -18.3 % | -26.4 % | −47.4 % | +45.9 % | 15 | 24 | 5.0 % | 4.5 % | 0.66 | 24.4 | 14.7 | 0.8 | 2.1 | 12.1 | — | 13.7 | 6.3 % | 22.8 % | 3.6 % | 11.0 % | 4.4 % | 0.63 | 44.1 % | -5.7 % | 0.0 % | 0.0 % | 6.2 | 101.9 % | 16.5 % | 1.5 (11) |
| ROCK Gibraltar Industries Inc | 08/05 | -11 % | 23 4/29 | Stage 4 | D -24 | 2 of 9 | 1.3 | Building Products & Equipmen | – | — | — | Industrials | 43.60 $ | -20.5 % | -10.9 % | -27.8 % | −41.1 % | +55.4 % | 15 | 24 | 4.9 % | 4.7 % | 1.21 | 21.2 | 11.5 | 1.1 | 1.5 | 18.7 | 0.77 | 20.7 | 6.1 % | 26.1 % | -10.7 % | 6.6 % | 3.9 % | 1.56 | 31.6 % | -13.2 % | 0.0 % | 0.0 % | 5.3 | 107.5 % | 7.3 % | 1.0 (3) |
| CRAI CRA International Inc | 07/30 | +17 % | 76 9/29 | Stage 4 | C -3 | 2 of 9 | 0.9 | Consulting Services | – | — | — | Industrials | 171.50 $ | -27.7 % | -30.3 % | -20.0 % | −37.1 % | +76.6 % | 15 | 18 | 4.5 % | 4.4 % | 0.68 | 20.3 | 17.2 | 1.2 | 4.8 | — | 1.08 | 11.4 | — | 29.4 % | 6.2 % | 22.5 % | 7.5 % | 1.41 | — | +9.3 % | 1.6 % | 27.5 % | 4.8 | 88.1 % | 4.5 % | — |
| CLB Core Laboratories NV | 07/22 | -16 % | 29 1/10 | Stage 4 | C -5 | 4 of 9 | 0.5 | Oil & Gas Equipment & Servic | – | — | — | Energy | 11.20 $ | -27.3 % | -33.9 % | -7.6 % | −46.4 % | +45.0 % | 15 | 20 | 4.7 % | 4.6 % | 1.01 | 18.1 | 17.2 | 1.0 | 1.9 | 26.7 | 1.44 | 9.8 | — | 19.9 % | 5.5 % | 11.1 % | 4.9 % | 0.62 | — | +0.5 % | 0.4 % | 5.9 % | 6.9 | 113.7 % | 28.6 % | — |
| OPTU Optimum Communications, Inc. | 08/06 | -12 % | — | Stage 4 | D -46 | 4 of 9 | 0.0 | Telecom Services | – | — | — | Communication Services | 0.83 $ | -18.2 % | -10.6 % | -21.1 % | −46.3 % | -25.7 % | 15 | 50 | 13.6 % | 16.5 % | 1.15 | — | 28.2 | — | 28.8 | — | 1.06 | 16.7 | — | 69.5 % | -55.0 % | 0.0 % | 3.3 % | -5.13 | — | -4.1 % | 0.0 % | 0.0 % | 2.1 | 102.3 % | 45.1 % | — |
| SHOE Shoe Station Group Inc. | — | -9 % | — | Stage 4 | D -27 | 3 of 9 | 0.0 | Apparel Retail | – | — | — | Consumer Cyclical | 14.90 $ | -8.0 % | -13.5 % | -12.2 % | −41.2 % | +40.8 % | 15 | 50 | 5.0 % | 4.8 % | 1.42 | — | 10.1 | — | — | — | — | 7.3 | — | 36.3 % | 3.3 % | 5.6 % | 3.4 % | — | — | -5.6 % | 4.2 % | 35.8 % | 9.7 | 74.3 % | 17.7 % | — |
| KROS Keros Therapeutics Inc | 08/05 | -25 % | 2 0/22 | Stage 4 | D -34 | 3 of 9 | 0.2 | Biotechnology | – | — | — | Healthcare | 10.60 $ | -46.0 % | -48.8 % | -20.6 % | −53.8 % | +109.7 % | 15 | 42 | 4.9 % | 5.1 % | 0.97 | — | 48.8 | 6.2 | — | — | — | -13.0 | — | -184.9 % | -256.6 % | -16.8 % | -12.2 % | — | — | +6,775.0 % | 0.0 % | 0.0 % | 13.1 | 96.2 % | 8.2 % | — |
| HDSN Hudson Technologies Inc | 07/29 | -13 % | 22 3/23 | Stage 4 | D -19 | 4 of 9 | 0.2 | Specialty Chemicals | – | — | — | Basic Materials | 6.10 $ | -15.9 % | -21.3 % | -26.9 % | −47.1 % | +52.6 % | 15 | 5 | 3.9 % | 4.1 % | 0.78 | 17.4 | 14.3 | 0.9 | 1.0 | — | 0.39 | 10.3 | — | 24.6 % | 5.7 % | 5.9 % | 4.3 % | 0.02 | — | +4.0 % | 0.0 % | 0.0 % | 11.9 | 81.3 % | 4.0 % | — |
| SIGA SIGA Technologies Inc | 08/04 | +4 % | 15 2/22 | Stage 4 | D -20 | 0 of 9 | 0.3 | Drug Manufacturers - Special | – | — | — | Healthcare | 3.50 $ | -20.4 % | -34.9 % | -21.1 % | −58.9 % | +343.8 % | 15 | 98 | 4.1 % | 3.6 % | 0.89 | 14.1 | 27.5 | 3.0 | 1.9 | 10.4 | 3.37 | 6.2 | — | 43.6 % | 21.6 % | 11.0 % | 5.5 % | 0.00 | — | -31.8 % | 9.5 % | 2.2 % | 9.5 | 49.9 % | 7.4 % | — |
| RR Richtech Robotics Inc. Class B Common Stock | 07/01 | — | 37 5/29 | Stage 4 | D -12 | 4 of 9 | 0.4 | Specialty Industrial Machinery | – | — | — | Industrials | 1.60 $ | -37.5 % | -45.8 % | +7.3 % | −74.6 % | +111.6 % | 15 | 42 | 7.4 % | 9.5 % | -0.85 | — | 0.0 | 85.9 | 1.3 | — | — | 0.0 | — | 55.8 % | 0.0 % | -10.6 % | -8.1 % | 0.00 | — | +19.0 % | 0.0 % | 0.0 % | 45.2 | 40.4 % | 27.4 % | — |
| SERA Sera Prognostics Inc | 08/05 | -31 % | 58 5/22 | Stage 4 | D -37 | 2 of 9 | 0.1 | Medical Devices | – | — | — | Healthcare | 2.10 $ | -37.6 % | -49.7 % | -3.7 % | −56.0 % | +205.6 % | 15 | 42 | 6.5 % | 9.2 % | 0.97 | — | 0.0 | — | 1.1 | — | — | -0.6 | — | -191.2 % | 0.0 % | -39.6 % | -21.6 % | 0.04 | — | +5.2 % | 0.0 % | 0.0 % | -5.6 | 63.1 % | 0.9 % | — |
| GPK Graphic Packaging Holding Company | 08/04 | -18 % | 32 5/31 | Stage 4 | D -23 | 3 of 9 | 3.2 | Packaging & Containers | – | — | — | Consumer Cyclical | 10.80 $ | -30.6 % | -28.0 % | -48.3 % | −54.1 % | +8.0 % | 14 | 15 | 4.2 % | 4.6 % | 0.68 | — | 14.5 | 0.4 | — | 20.8 | 3.33 | 7.7 | 4.1 % | 17.0 % | 3.2 % | 8.6 % | 3.8 % | — | 27.8 % | -2.2 % | 4.1 % | 36.7 % | 4.9 | 117.7 % | 10.9 % | 2.1 (10) |
| PFSI PennyMac Finl Svcs Inc | 07/28 | +8 % | 13 2/22 | Stage 4 | C +9 | 3 of 9 | 4.4 | Mortgage Finance | – | — | — | Financial Services | 83.60 $ | -38.7 % | -35.3 % | -13.0 % | −47.4 % | +24.6 % | 14 | 57 | 3.5 % | 3.0 % | 1.43 | — | 5.4 | 1.2 | — | — | 4.67 | 47.3 | 14.6 % | 87.2 % | 15.3 % | 12.3 % | 1.8 % | — | 13.5 % | +173.8 % | 1.4 % | 10.1 % | 5.8 | 66.9 % | 7.7 % | 1.3 (8) |
| YELP Yelp Inc | 08/06 | -12 % | 75 7/24 | Stage 4 | C +4 | 4 of 9 | 1.3 | Internet Content & Informati | – | — | — | Communication Services | 26.30 $ | -25.4 % | -20.0 % | -31.6 % | −36.3 % | +15.9 % | 14 | 24 | 4.5 % | 4.8 % | 0.46 | — | 14.7 | 0.9 | — | 4.5 | 0.57 | 6.1 | 9.0 % | 90.0 % | 9.5 % | 20.5 % | 11.6 % | — | 62.3 % | +3.8 % | 0.0 % | 0.0 % | 2.7 | 116.7 % | 24.4 % | 2.0 (12) |
| RXRX Recursion Pharmaceuticals Inc | 08/04 | -19 % | 2 0/22 | Stage 4 | C -8 | 4 of 9 | 1.8 | Biotechnology | – | — | — | Healthcare | 2.90 $ | -22.7 % | -16.1 % | -33.1 % | −53.5 % | +98.9 % | 14 | 42 | 6.8 % | 7.9 % | 1.00 | — | 0.0 | 26.8 | — | — | — | -5.3 | — | -645.6 % | 0.0 % | -57.2 % | -27.7 % | — | — | +26.9 % | 0.0 % | 0.0 % | 1.3 | 68.8 % | 36.8 % | — |
| AVD American Vanguard Corporation | 07/30 | -28 % | 76 7/23 | Stage 4 | D -30 | 4 of 9 | 0.1 | Agricultural Inputs | – | — | — | Basic Materials | 2.50 $ | -33.0 % | -31.9 % | -32.2 % | −54.4 % | +344.4 % | 14 | 24 | 7.9 % | 7.6 % | 1.42 | — | 15.5 | 0.1 | — | — | 0.25 | 67.2 | — | 29.8 % | -8.7 % | -21.9 % | 1.1 % | — | — | -5.9 % | 0.0 % | 0.0 % | 6.7 | 67.6 % | 3.0 % | — |
| MDWD Mediwound Ltd | 08/13 | +12 % | 41 4/22 | Stage 4 | D -39 | 2 of 9 | 0.2 | Biotechnology | – | — | — | Healthcare | 14.70 $ | -23.8 % | -20.1 % | -21.8 % | −31.4 % | +106.8 % | 14 | 42 | 3.6 % | 4.3 % | 0.15 | — | 35.0 | 13.6 | 4.5 | — | — | -6.3 | — | 19.6 % | -180.3 % | -71.8 % | -23.5 % | 0.20 | — | -16.1 % | 0.0 % | 0.0 % | — | 58.2 % | 15.0 % | — |
| MGX Metagenomi, Inc. Common Stock | 08/11 | — | 7 1/22 | Stage 4 | D -28 | 3 of 9 | 0.0 | Biotechnology | Uses AI | — | — | Healthcare | 1.20 $ | -23.5 % | -31.0 % | -15.5 % | −69.9 % | +572.3 % | 14 | 42 | 6.5 % | 5.4 % | 0.70 | — | 0.0 | 2.2 | 0.3 | — | — | 0.0 | — | -321.0 % | 0.0 % | -49.0 % | -23.4 % | 0.28 | — | -51.8 % | 0.0 % | 0.0 % | 1.3 | 19.3 % | 5.8 % | — |
| SNTI Senti Biosciences Inc | 08/06 | -33 % | 89 8/22 | Stage 4 | C -5 | 3 of 9 | 0.0 | Biotechnology | – | — | — | Healthcare | 0.43 $ | -11.1 % | -3.5 % | -45.7 % | −62.9 % | +1,115.0 % | 14 | 42 | 7.4 % | 6.9 % | 2.05 | — | 0.0 | — | 13.0 | — | — | -0.3 | — | -98,897.4 % | 0.0 % | -255.0 % | -56.9 % | 7.46 | — | -100.0 % | 0.0 % | 0.0 % | -36.6 | 18.5 % | 3.6 % | — |
| BLDR Builders FirstSource Inc | 07/30 | -13 % | 1 0/29 | Stage 4 | D -22 | 3 of 9 | 9.5 | Building Products & Equipmen | – | — | — | Industrials | 72.70 $ | -25.4 % | -13.0 % | -28.3 % | −41.3 % | +9.8 % | 13 | 5 | 6.2 % | 5.4 % | 1.42 | 34.0 | 17.9 | 0.6 | 2.4 | 11.1 | 2.02 | 11.8 | 0.5 % | 29.9 % | 2.0 % | 7.0 % | 3.4 % | -39.00 | 35.4 % | -7.4 % | 0.0 % | 0.0 % | 5.0 | 101.9 % | 8.8 % | 1.2 (21) |
| ACI Albertsons Companies | 07/21 | -10 % | 90 6/16 | Stage 4 | D -21 | 4 of 9 | 6.8 | Grocery Stores | – | — | — | Consumer Defensive | 15.00 $ | -17.4 % | -20.6 % | -33.9 % | −39.6 % | +47.6 % | 13 | 23 | 4.1 % | 3.5 % | 0.25 | 35.1 | 6.2 | 0.1 | 3.7 | 3.2 | 1.24 | 6.5 | 1.7 % | 27.2 % | 0.3 % | 8.3 % | 4.1 % | 24.08 | 6.9 % | +3.5 % | 4.8 % | 37.8 % | 3.4 | 99.9 % | 14.9 % | 1.5 (21) |
| AI C3 Ai Inc | — | -24 % | 34 4/25 | Stage 4 | D -42 | 1 of 9 | 1.3 | Software - Infrastructure | – | — | — | Technology | 8.60 $ | -28.2 % | -36.8 % | -60.2 % | −70.9 % | +0.8 % | 13 | 42 | 6.0 % | 6.7 % | 2.05 | — | 0.0 | 5.1 | 2.2 | — | — | -2.3 | — | 30.9 % | -188.0 % | -63.1 % | -33.1 % | — | — | -35.7 % | 0.0 % | 0.0 % | 1.1 | 63.9 % | 31.6 % | — |
| MGPI MGP Ingredients Inc | 07/30 | -27 % | 29 2/16 | Stage 4 | D -14 | 3 of 9 | 0.3 | Beverages - Wineries & Disti | – | — | — | Consumer Defensive | 18.20 $ | -29.5 % | -30.0 % | -41.9 % | −51.0 % | +71.3 % | 13 | 19 | 3.9 % | 3.6 % | 0.46 | — | 11.1 | 0.7 | 0.6 | 6.3 | 1.14 | 19.2 | — | 36.4 % | -46.0 % | -34.1 % | 3.9 % | 0.44 | — | -23.8 % | 2.8 % | 18.5 % | 5.9 | 73.3 % | 6.3 % | — |
| CTGO Contango ORE Inc | 08/12 | -12 % | 22 3/23 | Stage 4 | D -41 | 4 of 9 | 0.5 | Gold | – | — | — | Basic Materials | 15.30 $ | -40.8 % | -46.5 % | -30.3 % | −56.6 % | +156.9 % | 13 | 42 | 6.5 % | 6.7 % | -0.02 | — | 2.1 | — | 1.5 | — | — | 34.2 | — | — | 0.0 % | -18.5 % | -0.7 % | 0.10 | — | — | 0.0 % | 0.0 % | 3.7 | 36.8 % | 6.3 % | — |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Stage 4 + very weak RS (≤ 15) + price below the 200-day SMA — multiple weakness signals bundled together.
All scanners are recalculated daily across the entire stock universe — most recently on 21. July 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 211 stocks pass this scanner's criteria (as of 21. July 2026). The 25 strongest hits are shown.
Global filters: 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); fundamentally healthy names (Piotroski ≥ 5 or Funda Rating ≥ +10) are excluded.
This scanner deliberately hunts for red flags — a hit is a finding, not a recommendation: like a smoke detector that beeps so you look in time. A hit is also not a bankruptcy verdict; most companies save themselves (say, through a capital raise, which dilutes existing shareholders). Portfolio owners use the list as an early-warning system, bargain hunters as an anti-shopping list, experienced traders as a watch list — it is never a buy or short recommendation.
Related scanners
- Altman Z: Distress Zone
- Below the 50- & 200-SMA
- Beneish M-Score
- Downward Momentum
- Going Concern (Distress Proxy)
- Insolvency Radar: Cash Running Low
- Kathy Donnelly: Liquid Movers Down
- Mike Webster: Overextended (Webby RSI)
- Near 52-Week Low
- Pradeep Bonde: $ Breakout Bearish
- Pradeep Bonde: 4% Breakout Bearish
- Qullamaggie: Parabolic (Short-Watch)
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Thomas Insolvency Candidate
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.